Newsfile Corp
02 Aug 2026, 18:06 UTC · 12w ago
ROSEN, A NATIONAL INVESTOR RIGHTS FIRM, Encourages PROCEPT BioRobotics Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action - PRCT
Impact · against what's priced in
Procept BioRobotics faces significant valuation risk due to allegations of revenue manipulation via an undisclosed discount program and a massive surplus of field inventory. These claims suggest that reported growth was artificial and that future revenue is compromised by a pull-forward of demand.
- PRCT−0.80
No priced-in read yet





